Skip to content

MiMedx Group MDXG Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

IAR
Integra LifeSciencesIART
Artivion logo
ArtivionAORT
Solventum logo
SolventumSOLV
Vericel logo
VericelVCEL
Enovis logo
EnovisENOV
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total debt$17.6M-5.7%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Reported directly by MiMedx Group in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's accrued liabilities, current?
MiMedx Group (MDXG) reported accrued liabilities, current of $11.01M in Q1 2026.
How has MiMedx Group's accrued liabilities, current changed year-over-year?
MiMedx Group's accrued liabilities, current increased by 16.5% year-over-year, from $9.45M to $11.01M.
What is the long-term trend for MiMedx Group's accrued liabilities, current?
Over 5 years (2020 to 2025), MiMedx Group's accrued liabilities, current has grown at a -17.9% compound annual growth rate (CAGR), from $30.46M to $11.38M.